Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2009 1
2011 1
2012 2
2013 4
2014 5
2015 6
2016 6
2017 6
2018 11
2019 8
2020 10
2021 13
2022 13
2023 10
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

94 results

Results by year

Filters applied: . Clear all
Page 1
Infectious Diseases Society of America 2022 Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa).
Tamma PD, Aitken SL, Bonomo RA, Mathers AJ, van Duin D, Clancy CJ. Tamma PD, et al. Among authors: mathers aj. Clin Infect Dis. 2022 Aug 25;75(2):187-212. doi: 10.1093/cid/ciac268. Clin Infect Dis. 2022. PMID: 35439291 Free PMC article.
Clinical challenges treating Stenotrophomonas maltophilia infections: an update.
Mojica MF, Humphries R, Lipuma JJ, Mathers AJ, Rao GG, Shelburne SA, Fouts DE, Van Duin D, Bonomo RA. Mojica MF, et al. Among authors: mathers aj. JAC Antimicrob Resist. 2022 May 5;4(3):dlac040. doi: 10.1093/jacamr/dlac040. eCollection 2022 Jun. JAC Antimicrob Resist. 2022. PMID: 35529051 Free PMC article. Review.
Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa).
Tamma PD, Aitken SL, Bonomo RA, Mathers AJ, van Duin D, Clancy CJ. Tamma PD, et al. Among authors: mathers aj. Clin Infect Dis. 2021 Apr 8;72(7):e169-e183. doi: 10.1093/cid/ciaa1478. Clin Infect Dis. 2021. PMID: 33106864
Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa).
Tamma PD, Aitken SL, Bonomo RA, Mathers AJ, van Duin D, Clancy CJ. Tamma PD, et al. Among authors: mathers aj. Clin Infect Dis. 2021 Apr 8;72(7):1109-1116. doi: 10.1093/cid/ciab295. Clin Infect Dis. 2021. PMID: 33830222
Effect and Safety of Meropenem-Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections: The TANGO II Randomized Clinical Trial.
Wunderink RG, Giamarellos-Bourboulis EJ, Rahav G, Mathers AJ, Bassetti M, Vazquez J, Cornely OA, Solomkin J, Bhowmick T, Bishara J, Daikos GL, Felton T, Furst MJL, Kwak EJ, Menichetti F, Oren I, Alexander EL, Griffith D, Lomovskaya O, Loutit J, Zhang S, Dudley MN, Kaye KS. Wunderink RG, et al. Among authors: mathers aj. Infect Dis Ther. 2018 Dec;7(4):439-455. doi: 10.1007/s40121-018-0214-1. Epub 2018 Oct 1. Infect Dis Ther. 2018. PMID: 30270406 Free PMC article.
Collaborative Antimicrobial Stewardship for Surgeons.
Robinson ED, Volles DF, Kramme K, Mathers AJ, Sawyer RG. Robinson ED, et al. Among authors: mathers aj. Infect Dis Clin North Am. 2020 Mar;34(1):97-108. doi: 10.1016/j.idc.2019.11.002. Infect Dis Clin North Am. 2020. PMID: 32008698 Review.
Reply to Davis et al.
Tamma PD, Mathers AJ, Wenzler E. Tamma PD, et al. Among authors: mathers aj. Clin Infect Dis. 2023 Jul 5;77(1):163-165. doi: 10.1093/cid/ciad170. Clin Infect Dis. 2023. PMID: 36978246 No abstract available.
94 results